JNJ
Income statement / Annual
Last year (2023), Johnson & Johnson's total revenue was $85.16 B,
an increase of 6.46% from the previous year.
In 2023, Johnson & Johnson's net income was $35.15 B.
See Johnson & Johnson’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
01/01/2023 |
01/02/2022 |
01/03/2021 |
12/29/2019 |
12/30/2018 |
12/31/2017 |
01/01/2017 |
01/03/2016 |
12/28/2014 |
| Operating Revenue |
$85.16 B
|
$79.99 B
|
$78.74 B
|
$82.58 B
|
$82.06 B
|
$81.58 B
|
$76.45 B
|
$71.89 B
|
$70.07 B
|
$74.33 B
|
| Cost of Revenue |
$26.55 B |
$24.60 B |
$23.40 B |
$28.43 B |
$27.56 B |
$27.09 B |
$25.35 B |
$21.69 B |
$21.54 B |
$22.75 B |
| Gross Profit |
$58.61 B |
$55.39 B |
$55.34 B |
$54.16 B |
$54.50 B |
$54.49 B |
$51.10 B |
$50.21 B |
$48.54 B |
$51.59 B |
| Gross Profit Ratio |
0.69 |
0.69 |
0.7 |
0.66 |
0.66 |
0.67 |
0.67 |
0.7 |
0.69 |
0.69 |
| Research and Development
Expenses |
$15.09 B
|
$14.14 B
|
$14.28 B
|
$12.34 B
|
$11.36 B
|
$10.78 B
|
$10.55 B
|
$9.10 B
|
$9.05 B
|
$8.49 B
|
| General & Administrative
Expenses |
$20.11 B
|
$19.05 B
|
$20.12 B
|
$22.08 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$20.11 B
|
$19.05 B
|
$20.12 B
|
$22.08 B
|
$22.18 B
|
$22.54 B
|
$21.42 B
|
$19.95 B
|
$21.20 B
|
$21.95 B
|
| Other Expenses |
$0.00 |
$500.00 M |
-$526.00 M |
-$2.90 B |
-$2.53 B |
-$1.41 B |
-$183.00 M |
-$484.00 M |
$2.06 B |
$70.00 M |
| Operating Expenses |
$58.61 B |
$33.18 B |
$34.40 B |
$34.42 B |
$33.53 B |
$33.32 B |
$31.97 B |
$29.04 B |
$30.25 B |
$30.45 B |
| Cost And Expenses |
$61.75 B |
$57.78 B |
$57.80 B |
$62.85 B |
$61.09 B |
$60.41 B |
$57.33 B |
$50.73 B |
$51.79 B |
$53.19 B |
| Interest Income |
$1.26 B |
$490.00 M |
$53.00 M |
$111.00 M |
$357.00 M |
$611.00 M |
$385.00 M |
$368.00 M |
$128.00 M |
$67.00 M |
| Interest Expense |
$772.00 M |
$276.00 M |
$183.00 M |
$201.00 M |
$318.00 M |
$1.01 B |
$934.00 M |
$726.00 M |
$552.00 M |
$533.00 M |
| Depreciation &
Amortization |
$7.49 B
|
$6.97 B
|
$7.39 B
|
$7.23 B
|
$7.01 B
|
$6.93 B
|
$5.64 B
|
$3.75 B
|
$3.75 B
|
$3.90 B
|
| EBITDA |
$23.73 B
|
$27.17 B
|
$30.93 B
|
$27.50 B
|
$28.27 B
|
$28.10 B
|
$24.54 B
|
$24.92 B
|
$22.12 B
|
$25.03 B
|
| EBITDA Ratio |
0.28 |
0.38 |
0.35 |
0.29 |
0.27 |
0.28 |
0.26 |
0.3 |
0.27 |
0.29 |
| Operating Income Ratio
|
0.27
|
0.29
|
0.26
|
0.21
|
0.18
|
0.19
|
0.19
|
0.25
|
0.22
|
0.23
|
| Total Other
Income/Expenses Net |
-$8.35 B
|
-$2.85 B
|
-$1.77 B
|
-$3.24 B
|
$2.21 B
|
$2.38 B
|
-$1.22 B
|
-$1.09 B
|
$907.00 M
|
-$574.00 M
|
| Income Before Tax |
$15.06 B |
$19.36 B |
$19.18 B |
$16.50 B |
$17.33 B |
$18.00 B |
$17.67 B |
$19.80 B |
$19.20 B |
$20.56 B |
| Income Before Tax Ratio
|
0.18
|
0.24
|
0.24
|
0.2
|
0.21
|
0.22
|
0.23
|
0.28
|
0.27
|
0.28
|
| Income Tax Expense |
$1.74 B |
$2.99 B |
$1.38 B |
$1.78 B |
$2.21 B |
$2.70 B |
$16.37 B |
$3.26 B |
$3.79 B |
$4.24 B |
| Net Income |
$35.15 B |
$17.94 B |
$20.88 B |
$14.71 B |
$15.12 B |
$15.30 B |
$1.30 B |
$16.54 B |
$15.41 B |
$16.32 B |
| Net Income Ratio |
0.41 |
0.22 |
0.27 |
0.18 |
0.18 |
0.19 |
0.02 |
0.23 |
0.22 |
0.22 |
| EPS |
13.88 |
6.86 |
7.93 |
5.59 |
5.74 |
5.75 |
0.48 |
6.08 |
5.57 |
5.86 |
| EPS Diluted |
13.73 |
6.73 |
7.81 |
5.51 |
5.63 |
5.61 |
0.47 |
5.93 |
5.48 |
5.7 |
| Weighted Average Shares
Out |
$2.53 B
|
$2.61 B
|
$2.63 B
|
$2.63 B
|
$2.63 B
|
$2.66 B
|
$2.68 B
|
$2.71 B
|
$2.76 B
|
$2.78 B
|
| Weighted Average Shares
Out Diluted |
$2.56 B
|
$2.66 B
|
$2.67 B
|
$2.67 B
|
$2.68 B
|
$2.73 B
|
$2.75 B
|
$2.79 B
|
$2.81 B
|
$2.86 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
